Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News HAVN Life Sciences Inc HAVLF


Primary Symbol: C.HAVN

HAVN Life Sciences Inc. is a Canada-based biotechnology company. The Company is engaged in the scientific research and development of psychopharmacological and natural health care products. It is focused on standardizing extraction of psychoactive compounds, the development of natural health products, and developing mental health treatments to support brain health and enhance the capabilities... see more

Recent & Breaking News (CSE:HAVN)

Havn Life Completes Acquisition of Strategic Manufacturing & Packaging Facility for its Retail Division

Accesswire April 8, 2021

Havn Life Sciences Signs LOI to Research and Develop Medical Psilocybin with Jamaican Company Hypha Wellness

Accesswire March 25, 2021

Havn Life CEO to Present at Zooming with LD, a Leading Platform for Microcap Companies

Accesswire March 19, 2021

Health Conscious Consumers are Rapidly Turning to Functional Mushrooms

Livemoney March 16, 2021

Havn Life Introduces Industry Leader Jenna Pozar as Chief Operating Officer

Accesswire March 16, 2021

Havn Life Sciences to Host Investor Webcast on March 3, 2021

Accesswire February 26, 2021

This is Why Global Demand for Functional Mushrooms is On the Rise

Livemoney February 22, 2021

Havn Life Announces Changes to Board Composition and Departure of Ms. Rasode

Accesswire February 17, 2021

The Top Reasons Consumer Demand for Functional Mushrooms is on the Rise

Livemoney February 10, 2021

The Functional Mushroom Market Could Hand You a $62 Billion Opportunity

Livemoney February 3, 2021

Havn Life Announces Strategic Clinical Trial Partnership with HealthTech Connex Inc.

Accesswire February 2, 2021

Medicinal Mushrooms Could Be as Rewarding as the Cannabis Boom

Livemoney January 28, 2021

This New Psychedelics ETF Could Be One of the Hottest Ideas of 2021. Here's Why

Livemoney January 26, 2021

Havn Life Sciences Enters Definitive Agreement to Acquire Strategic Manufacturing & Packaging Facility for its Retail Division

Accesswire January 26, 2021

Havn Life Sciences Announces Inclusion in First Psychedelic Exchange Traded Fund

Accesswire January 22, 2021

Havn Life to Support Canadian Counterpart of Veterans' Organization, Heroic Hearts

Accesswire January 18, 2021

Psilocybin is Being Studied to Help Treat Autism Spectrum Disorder

Livemoney January 13, 2021

New Psychedelics Studies Could Shed Light on Treatment for Obesity Epidemic

Livemoney January 12, 2021

Havn Life Sciences announces closing of C$11.5 million Bought Deal Financing

Accesswire January 7, 2021

Big Pharmaceuticals Could Enter the Psychedelics Space in 2021

Livemoney January 4, 2021